VIDEO: Teprotumumab efficacy sustained after 6 months in thyroid eye disease

ByPrem Subramanian, MD, PhD

Add topic to email alerts

Please provide your email address to receive an email when new articles are posted on Gynecologic Cancer.

Subscribe

Added to email alerts

You've successfully added Gynecologic Cancer to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added Gynecologic Cancer to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

AUSTIN, Texas — In this Healio Video Perspective from the North American Neuro-Ophthalmology Society meeting, Prem Subramanian, MD, PhD, discusses the sustained efficacy of teprotumumab in patients with thyroid eye disease.

Published by:

Sources/Disclosures

Collapse

Source:

Prem Subramanian, MD, PhD

Read more from North American Neuro-Ophthalmology Society

View all

June 19, 2023

1 min read

Save

Study examines risk factors for ischemic stroke after acute retinal arterial ischemia

May 10, 2023

1 min read

Save

Parkinson’s disease duration can affect visual field sensitivity

May 10, 2023

1 min read

Save

Parkinson’s disease duration can affect visual field sensitivity

May 02, 2023

1 min read

Save

Study provides update on NAION risk factors, prevalence in US

May 02, 2023

1 min read

Save

Study provides update on NAION risk factors, prevalence in US

April 21, 2023

1 min read

Save

Telehealth model may help manage patients with pseudotumor cerebri

April 21, 2023

1 min read

Save

Telehealth model may help manage patients with pseudotumor cerebri

April 17, 2023

1 min read

Save

Idiopathic intracranial hypertension rapidly increasing with obesity epidemic in US

April 14, 2023

1 min read

Save

Accelerated ‘papilledema protocol’ may save vision, lives

Previous

Next

Read more about

thyroid eye disease

teprotumumab

Add topic to email alerts

Please provide your email address to receive an email when new articles are posted on Gynecologic Cancer.

Subscribe

Added to email alerts

You've successfully added Gynecologic Cancer to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added Gynecologic Cancer to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

• Facebook
• Twitter
• LinkedIn
• Email
• Print
• Comment